Myriad’s Commitment to Fight Cancer May 29, 2019 Transforming Patients’ Lives with Pioneering Genetic Tests At Myriad, we are proud of our long-standing commitment to fighting cancer, which continues to exac... Continue Reading
EndoPredict is the Only Test to Answer Three Critical Questions December 7, 2018 EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine... Continue Reading